Pan HF, Ye DQ, Wang Q, Li WX, Zhang N, Li XP, Xu JH, Dai H. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjögren syndrome in China: a study of 542 patients. Clin Rheumatol. 2008;27:339–43.
Heaton JM. Sjögren’s syndrome and systemic lupus erythematosus. Br Med J. 1959;21(1):466–9.
Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, Massardo L, Molina-Restrepo JF, Toledano MG, Barile-Fabris LA, Amigo MC, Acevedo-Vásquez EM, Abadi I, Wojdyla D, Alarcón-Riquelme ME, Alarcón GS, Pons-Estel BA. GLADEL. Lupus in Latin-American patients: lessons from the GLADEL cohort. Lupus. 2015;24:536–45.
Article CAS PubMed Google Scholar
Rus V, Maury EE, Hochberg MC. The epidemiology of systemic lupus erythematosus. Dubois lupus erythematosus. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
Borba EF, et al. Systemic lupus erythematosus consensus. Braz J Rheumatol. 2008;48(4):196–207 (in Portuguese).
Jonsson H, Nived O, Sturfelt G, Silman A. Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol. 1990;29:185–8.
Article CAS PubMed Google Scholar
Yee CS, Su L, Toescu V, Hickman R, Situnayake D, Bowman S, Farewell V, Gordon C. Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years. Rheumatology (Oxford). 2015;54:836–43.
Article CAS PubMed Google Scholar
Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C, EULAR Sjögren's Task Force. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis. 2010;69(6):1103–9. https://doi.org/10.1136/ard.2009.110619. Erratum in: Ann Rheum Dis. 2011;70:880.
Valim V, et al. Prevalence of primary Sjögren syndrome in an important metropolitan area in Brazil. Braz J Rheumatol. 2013;53(1):29–34 (in Portuguese).
Gilboe IM, Kvien TK, Uhlig T, Husby G. Sicca symptoms and secondary Sjögren’s syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis. 2001;60:1103–9.
Article CAS PubMed PubMed Central Google Scholar
Pasoto SG, Adriano de Oliveira Martins V, Bonfa E. Sjögren’s syndrome and systemic lupus erythematosus: links and risks. Open Access Rheumatol. 2019;11:33–45.
Article CAS PubMed PubMed Central Google Scholar
Alani H, Henty JR, Thompson NL, Jury E, Ciurtin C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren’s syndrome (secondary Sjögren’s syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018;47:141–54.
Article CAS PubMed Google Scholar
Aggarwal R, Anaya JM, Koelsch KA, Kurien BT, Scofield RH. Association between secondary and primary Sjögren’s syndrome in a large collection of lupus families. Autoimmune Dis. 2015;2015:298506.
PubMed PubMed Central Google Scholar
Andonopoulos AP, Skopouli FN, Dimou GS, Drosos AA, Moutsopoulos HM. Sjögren’s syndrome in systemic lupus erythematosus. J Rheumatol. 1990;17:201–4.
Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, Moutsopoulos HM. Sjögren’s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren’s syndrome. Arthritis Rheum. 2004;50:882–91.
Baer AN, Maynard JW, Shaikh F, Magder LS, Petri M. Secondary Sjogren’s syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol. 2010;37:1143–9.
Yao Q, Altman RD, Wang X. Systemic lupus erythematosus with Sjögren syndrome compared to systemic lupus erythematosus alone: a meta-analysis. J Clin Rheumatol. 2012;18:28–32.
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjögren’s Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9–16.
Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara NA, Greenspan JS, Daniels TE, Sjögren’s International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol. 2010;149:405–15.
Giovelli RA. Retrospective histological analysis of minor salivary gland in patients with dry syndrome. Master’s thesis, Federal University of Espírito Santo; 2013 (in Portuguese).
Le Goff M, Cornec D, Jousse-Joulin S, Guellec D, Costa S, Marhadour T, Le Berre R, Genestet S, Cochener B, Boisrame-Gastrin S, Renaudineau Y, Pers JO, Saraux A, Devauchelle-Pensec V. Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome. Arthritis Res Ther. 2017;6(19):269.
Grennan DM, Ferguson M, Ghobarey AE, Williamson J, Dick WC, Buchanan WW. Sjogren’s syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren’s syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma. N Z Med J. 1977;86:376–9.
Cervera R, García-Carrasco M, Font J, Ramos M, Reverter JC, Muñoz FJ, Miret C, Espinosa G, Ingelmo M. Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol. 1997;15:361–5.
Witte T, Hartung K, Sachse C, Matthias T, Fricke M, Kalden JR, Lakomek HJ, Peter HH, Schmidt RE. Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters. SLE study group. Rheumatol Int. 2000;19:107–11.
Article CAS PubMed Google Scholar
Lee CW, Kang SG. Recurrent annular erythema in Sjögren’s/lupus erythematosus overlap syndrome: an additional case from Korea. J Dermatol. 1996;23:431–2.
Article CAS PubMed Google Scholar
Szántó A, Kiss E, Sas A, Szegedi G, Zeher M. Association of systemic lupus erythematosus and Sjögren’s syndrome. Orv Hetil. 2005;11(146):2533–8 (in Hungarian).
Xu D, et al. Patients with Sjögren’s syndrome-onset lupus have distinct clinical manifestations and a benign prognosis: a case-control study. Lupus. 2010;19:197–200 (in Portuguese).
Article CAS PubMed Google Scholar
Ghillani P, André C, Toly C, Rouquette AM, Bengoufa D, Nicaise P, Goulvestre C, Gleizes A, Dragon-Durey MA, Alyanakian MA, Chretien P, Chollet-Martin S, Musset L, Weill B, Johanet C. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study. Autoimmun Rev. 2011;10:509–13.
Article CAS PubMed Google Scholar
Yoshimasu T, Hiroi A, Ohtani T, Uede K, Furukawa F. Comparison of anti 60 and 52 kDa SS-A/Ro antibodies in the pathogenesis of cutaneous lupus erythematosus. J Dermatol Sci. 2002;29:35–41.
Article CAS PubMed Google Scholar
Bologna SB, Cavalcante WS, Florezi GP, Souza MM, Nico MMS, Lourenço SV. Distinct salivary gland features in Sjögren’s syndrome and lupus erythematosus sialadenite. Am J Dermatopathol. 2020;42:407–13.
留言 (0)